glp-1 postbiotic reviews Triquetra Health, PX Therapeutics™, GLP-Pro™ Probiotics + Postbiotic, 30 Capsules Boost Synergy GLP-1 Probiotic for

presented at ADA 2026 (June 6, 2026)

6 Emerging clinical applications 6.1 Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) Studies investigating GLP-1 receptor agonists for the prevention of NAFLD/NASH indicate potential effectiveness via several molecular mechanisms

Approval for Cardiovascular Risk Reduction Ongoing cardiovascular outcomes trials (CVOT) studies clearly demonstrated that three of the diabetes incretin medications (liraglutide, dulaglutide and semaglutide) and one of the weight loss versions of this class (Wegovy) also reduce cardiovascular disease risk

Loss of kidney function by 10 mL/min per 1.73 m per year, for example, would be expected to lead to total loss of kidney function within 12 years

Whether youre looking for a warm, savory dish or a cool, refreshing option, youll find breakfasts that suit your tastes while keeping you on track with your health goals

This development is aimed at giving patients an oral option with the same power as an injection